Avanos Medical, Inc. EPS (Earnings per Share) 2012–2025
Avanos Medical, Inc. reported $-1.57 of earnings per share for fiscal 2025. That was 81.6% higher than fiscal 2024. Compared with fiscal 2020, the change was -157.4%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-1.57 | +81.6% |
| FY 2024 | $-8.53 | -546.2% |
| FY 2023 | $-1.32 | -223.4% |
| FY 2022 | $1.07 | +723.1% |
| FY 2021 | $0.13 | +121.3% |
| FY 2020 | $-0.61 | +36.5% |
| FY 2019 | $-0.96 | -178.7% |
| FY 2018 | $1.22 | -27.8% |
| FY 2017 | $1.69 | +98.8% |
| FY 2016 | $0.85 | +109.3% |
| FY 2015 | $-9.15 | -1677.6% |
| FY 2014 | $0.58 | -82.5% |
| FY 2013 | $3.32 | +1.2% |
| FY 2012 | $3.28 | — |
Source: Avanos Medical, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AVNS 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Avanos Medical, Inc. reported $-1.57 of earnings per share for fiscal 2025. That was 81.6% higher than fiscal 2024. Compared with fiscal 2020, the change was -157.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Avanos Medical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAvanos Medical, Inc. — frequently asked questions
What is Avanos Medical, Inc.'s earnings per share?
Avanos Medical, Inc. (AVNS) reported earnings per share of $-1.57 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Avanos Medical, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.